title: Magnetic resonance imaging contrast agent related pulmonary edema: a case report.
abstract: Gadobutrol is a contrast agent often used during magnetic resonance imaging (MRI). The agent has several side effects, some of which can be serious. It has extremely rare life-threatening systemic complications, which can lead to bronchospasm, hypersensitivity reactions and cardiovascular arrest. However, there is no data available on the development of noncardiogenic pulmonary edema following use of gadobutrol. This paper examines the case of a 37-year-old male patient reported to have developed noncardiogenic pulmonary edema after intravenous injection of gadobutrol during MRI.
authors.affiliation: Department of Anesthesiology and Reanimation, Abant Izzet Baysal, University Medical School, Bolu, Turkey. dr_demirhan1@hotmail.com
authors.forename: A
authors.initials: A
authors.lastname: Demirhan
authors.forename: U
authors.initials: U
authors.lastname: Yasar Tekelioglu
authors.forename: A
authors.initials: A
authors.lastname: Akkaya
authors.forename: E
authors.initials: E
authors.lastname: Dagistan
authors.forename: S
authors.initials: S
authors.lastname: Suzi Ayhan
authors.forename: S
authors.initials: S
authors.lastname: Ozturk
authors.forename: I
authors.initials: I
authors.lastname: Yildiz
authors.forename: H
authors.initials: H
authors.lastname: Kocoglu
mesh_terms: D000328:Adult; D003287:Contrast Media / Q000009:adverse effects*; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000009:adverse effects*; D008297:Male; D009942:Organometallic Compounds / Q000009:adverse effects*; D011654:Pulmonary Edema / Q000139:chemically induced*
chemical_list: D003287:Contrast Media; D009942:Organometallic Compounds; C090600:gadobutrol